Arrowstreet Capital’s Anterix ATEX Stock Holding History

Arrowstreet Capital’s Portfolio ATEX Stock Details ATEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-33,401	Closed	-$729K	–	1834
2025 Q4	$729K	Buy	+33,401	New	+$694K	﹤0.01%	1611
2021 Q2	–	Sell	-6,300	Closed	-$297K	–	1865
2021 Q1	$297K	Buy	+6,300	New	+$259K	﹤0.01%	2089

Other funds holding ATEX

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

HCL

Heard Capital LLC Chicago, Illinois $1.93B AUM 21.66% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Plustick Management Charlottesville, Virginia $207M AUM 253.94% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital's ATEX Position: Q1 2026 in Review

Arrowstreet Capital sold out of Anterix (ATEX) in Q1 2026, closing a stake of 33,401 shares — an estimated $729K sold.

Arrowstreet Capital first reported a position in ATEX in Q1 2021 and held it in 2 quarters. The position peaked at $729K in Q4 2025. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

Arrowstreet Capital reported no remaining Anterix position as of Q1 2026 after selling out during the quarter.
Arrowstreet Capital sold 33,401 Anterix shares in Q1 2026, an estimated $729K.
Arrowstreet Capital first reported a position in Anterix in Q1 2021 and held it in 2 quarters.
Arrowstreet Capital's Anterix position peaked at $729K in Q4 2025.
132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.